277 related articles for article (PubMed ID: 11026799)
21. The predominance of IgG4 in prodromal bullous pemphigoid.
Lamb PM; Patton T; Deng JS
Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
[TBL] [Abstract][Full Text] [Related]
22. Bullous pemphigoid: from bench to bedside.
Walsh SR; Hogg D; Mydlarski PR
Drugs; 2005; 65(7):905-26. PubMed ID: 15892587
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
Honl BA; Elston DM
Cutis; 1998 Aug; 62(2):85-6. PubMed ID: 9714904
[TBL] [Abstract][Full Text] [Related]
24. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of pemphigoid nodularis with serological assay.
Zhiliang L; Peiying J; Suying F
G Ital Dermatol Venereol; 2016 Feb; 151(1):116-7. PubMed ID: 26924030
[No Abstract] [Full Text] [Related]
26. Systemic minocycline as a therapeutic option in predominantly oral mucous membrane pemphigoid: a cautionary report.
Carrozzo M; Arduino P; Bertolusso G; Cozzani E; Parodi A
Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1071-6. PubMed ID: 19628373
[TBL] [Abstract][Full Text] [Related]
27. Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium.
Tursen U; Guney A; Kaya T; Ikizoglu G
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):542-4. PubMed ID: 17373988
[No Abstract] [Full Text] [Related]
28. A dilemma: bullous-pemphigoid-like eruption in scabies or scabies-induced bullous pemphigoid.
Balighi K; Robati RM; Hejazi N
Dermatol Online J; 2006 May; 12(4):13. PubMed ID: 17083868
[TBL] [Abstract][Full Text] [Related]
29. [Bullous pemphigoid manifesting as dyshidrotic eczema and prurigo nodularis].
Braun B; Baima B; Sticherling M
Hautarzt; 2002 Nov; 53(11):739-43. PubMed ID: 12402137
[TBL] [Abstract][Full Text] [Related]
30. Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: defining a niche for these low toxicity agents.
McCarty M; Fivenson D
J Am Acad Dermatol; 2014 Sep; 71(3):475-9. PubMed ID: 24906610
[TBL] [Abstract][Full Text] [Related]
31. [Pemphigoid in children].
Misery L; Jay P; Kanitakis J; Chouvet B; Cozzani E; Faure M; Claudy A
Ann Dermatol Venereol; 1994; 121(9):623-5. PubMed ID: 7771729
[TBL] [Abstract][Full Text] [Related]
32. Management of bullous pemphigoid: recommendations for immunomodulatory treatments.
Kirtschig G; Khumalo NP
Am J Clin Dermatol; 2004; 5(5):319-26. PubMed ID: 15554733
[TBL] [Abstract][Full Text] [Related]
33. Localized bullous pemphigoid occurring in a surgical wound.
Massa MC; Freeark RJ; Kang JS
Dermatol Nurs; 1996 Apr; 8(2):101-3. PubMed ID: 8703608
[TBL] [Abstract][Full Text] [Related]
34. Oral and topical corticosteroids in bullous pemphigoid.
Korman NJ
N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117000
[No Abstract] [Full Text] [Related]
35. Skin tears?
Kazandjian DG; Okulicz JF
Am J Med; 2006 Aug; 119(8):657-9. PubMed ID: 16887409
[No Abstract] [Full Text] [Related]
36. Two Cases of Dermatitis Herpetiformis Successfully Treated with Tetracycline and Niacinamide.
Wang Y; Yang B; Zhou G; Zhang F
Acta Dermatovenerol Croat; 2018 Oct; 26(3):273-275. PubMed ID: 30390734
[TBL] [Abstract][Full Text] [Related]
37. Bullous pemphigoid controlled by tetracycline.
Thornfeldt CR; Menkes AW
J Am Acad Dermatol; 1987 Feb; 16(2 Pt 1):305-10. PubMed ID: 3546415
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of interferon-gamma in patients with refractory bullous pemphigoid.
Nakama T; Ishii N; Ono F; Hamada T; Yasumoto S; Hashimoto T
J Dermatol; 2007 Nov; 34(11):737-45. PubMed ID: 17973812
[TBL] [Abstract][Full Text] [Related]
40. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test.
Barnadas MA; Gilaberte M; Pujol R; Agustí M; Gelpí C; Alomar A
Int J Dermatol; 2006 Sep; 45(9):1089-92. PubMed ID: 16961518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
